• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长抑素类似物治疗主要诱导神经内分泌细胞中微小RNA(miRNA)表达变化并上调生长抑制性miR-7和miR-148a。

Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells.

作者信息

Døssing Kristina B V, Kjær Christina, Vikeså Jonas, Binderup Tina, Knigge Ulrich, Culler Michael D, Kjær Andreas, Federspiel Birgitte, Friis-Hansen Lennart

机构信息

Center for Genomic Medicine, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.

Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark.

出版信息

Genes (Basel). 2018 Jul 4;9(7):337. doi: 10.3390/genes9070337.

DOI:10.3390/genes9070337
PMID:29973528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6070923/
Abstract

Somatostatin (SST) analogues are used to control the proliferation and symptoms of neuroendocrine tumors (NETs). MicroRNAs (miRNA) are small non-coding RNAs that modulate posttranscriptional gene expression. We wanted to characterize the miRNAs operating under the control of SST to elucidate to what extent they mediate STT actions. NCI-H727 carcinoid cell line was treated with either a chimeric SST/dopamine analogue; a SST or dopamine analogue for proliferation assays and for identifying differentially expressed miRNAs using miRNA microarray. The miRNAs induced by SST analogue treatment are investigated in carcinoid cell lines NCI-H727 and CNDT2 using in situ hybridization, qPCR and proliferation assays. SST analogues inhibited the growth of carcinoid cells more potently compared to the dopamine analogue. Principal Component Analysis (PCA) of the samples based on miRNA expression clearly separated the samples based on treatment. Two miRNAs which were highly induced by SST analogues, miR-7 and miR-148a, were shown to inhibit the proliferation of NCI-H727 and CNDT2 cells. SST analogues also produced a general up-regulation of the let-7 family members. SST analogues control and induce distinct miRNA expression patterns among which miR-7 and miR-148a both have growth inhibitory properties.

摘要

生长抑素(SST)类似物用于控制神经内分泌肿瘤(NETs)的增殖和症状。微小RNA(miRNA)是调节转录后基因表达的小非编码RNA。我们想要表征在SST控制下发挥作用的miRNA,以阐明它们在多大程度上介导SST的作用。用嵌合SST/多巴胺类似物、SST或多巴胺类似物处理NCI-H727类癌细胞系,用于增殖测定以及使用miRNA微阵列鉴定差异表达的miRNA。使用原位杂交、qPCR和增殖测定在类癌细胞系NCI-H727和CNDT2中研究SST类似物处理诱导的miRNA。与多巴胺类似物相比,SST类似物更有效地抑制类癌细胞的生长。基于miRNA表达对样本进行主成分分析(PCA),根据处理情况清晰地分离了样本。由SST类似物高度诱导的两种miRNA,miR-7和miR-148a,显示出抑制NCI-H727和CNDT2细胞增殖的作用。SST类似物还使let-7家族成员普遍上调。SST类似物控制并诱导不同的miRNA表达模式,其中miR-7和miR-148a均具有生长抑制特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/d23297ac283d/genes-09-00337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/af7d85a9bb39/genes-09-00337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/6ad5d7954b57/genes-09-00337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/5e2cdab1fbf0/genes-09-00337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/f6e3fc49a661/genes-09-00337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/d23297ac283d/genes-09-00337-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/af7d85a9bb39/genes-09-00337-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/6ad5d7954b57/genes-09-00337-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/5e2cdab1fbf0/genes-09-00337-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/f6e3fc49a661/genes-09-00337-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d7/6070923/d23297ac283d/genes-09-00337-g005.jpg

相似文献

1
Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells.生长抑素类似物治疗主要诱导神经内分泌细胞中微小RNA(miRNA)表达变化并上调生长抑制性miR-7和miR-148a。
Genes (Basel). 2018 Jul 4;9(7):337. doi: 10.3390/genes9070337.
2
Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1.神经内分泌肿瘤及转移灶中miR-129-5p和let-7家族的下调导致其靶标Egr1、G3bp1、Hmga2和Bach1的上调。
Genes (Basel). 2014 Dec 24;6(1):1-21. doi: 10.3390/genes6010001.
3
Activin A regulates microRNAs and gene expression in LNCaP cells.激活素A调节LNCaP细胞中的微小RNA和基因表达。
Prostate. 2016 Aug;76(11):951-63. doi: 10.1002/pros.23184. Epub 2016 Mar 28.
4
Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death.miR-155-5p 的增加和 miR-148a-3p 的减少有助于抑制骨肉瘤细胞死亡。
Oncogene. 2016 Oct 6;35(40):5282-5294. doi: 10.1038/onc.2016.68. Epub 2016 Apr 4.
5
Regulation of the MIR155 host gene in physiological and pathological processes.miR-155 宿主基因在生理和病理过程中的调控。
Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14.
6
Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility.生长抑素及其类似物可降低 PDGF 诱导的子宫内膜细胞增殖和迁移。
Hum Reprod. 2012 Jul;27(7):2117-29. doi: 10.1093/humrep/des144. Epub 2012 May 15.
7
Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.微小RNA-26a和微小RNA-148a在胃癌中的表达及预后价值
J Gastroenterol Hepatol. 2017 Apr;32(4):819-827. doi: 10.1111/jgh.13533.
8
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.综述文章:生长抑素类似物治疗胃肠胰神经内分泌(类癌)肿瘤。
Aliment Pharmacol Ther. 2010 Jan 15;31(2):169-88. doi: 10.1111/j.1365-2036.2009.04174.x. Epub 2009 Oct 21.
9
Antagonistic activities of miR-148a and DNMT1: Ectopic expression of miR-148a impairs DNMT1 mRNA and dwindle cell proliferation and survival.miR-148a 和 DNMT1 的拮抗作用:miR-148a 的异位表达会损害 DNMT1 mRNA,并减少细胞增殖和存活。
Gene. 2018 Jun 20;660:68-79. doi: 10.1016/j.gene.2018.03.075. Epub 2018 Mar 26.
10
Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro.糖皮质激素在体外对人多巴胺D2和生长抑素受体亚型表达的差异调节
J Mol Endocrinol. 2009 Jan;42(1):47-56. doi: 10.1677/JME-08-0110. Epub 2008 Oct 13.

引用本文的文献

1
The Association of Neuroendocrine Differentiation with MicroRNA 21 and MicroRNA let7f Expression and the Clinicopathological Parameters in Primary Invasive Breast Carcinomas with Neuroendocrine Features.神经内分泌分化与微小RNA 21和微小RNA let7f表达以及具有神经内分泌特征的原发性浸润性乳腺癌临床病理参数的相关性
Diagnostics (Basel). 2024 Oct 3;14(19):2211. doi: 10.3390/diagnostics14192211.
2
Approaches based on natural products and miRNAs in pituitary adenomas: unveiling therapeutic intervention.垂体腺瘤中基于天然产物和微小RNA的方法:揭示治疗干预措施
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):69-88. doi: 10.1007/s00210-024-03347-6. Epub 2024 Aug 5.
3

本文引用的文献

1
Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.神经内分泌肺部肿瘤的低、中、高级别:解剖病理学诊断-预后和预测因素。
Mol Diagn Ther. 2018 Apr;22(2):169-177. doi: 10.1007/s40291-018-0315-2.
2
Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.胃肠胰神经内分泌肿瘤的医学治疗进展和现状。
Biomed Res Int. 2017;2017:9856140. doi: 10.1155/2017/9856140. Epub 2017 Nov 19.
3
Prognostic Factors in Typical and Atypical Pulmonary Carcinoids.
Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation.
胰腺神经内分泌肿瘤:信号通路与表观遗传调控
Int J Mol Sci. 2024 Jan 22;25(2):1331. doi: 10.3390/ijms25021331.
4
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies.类癌综合征:临床前模型与未来治疗策略。
Int J Mol Sci. 2023 Feb 10;24(4):3610. doi: 10.3390/ijms24043610.
5
Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future.循环神经内分泌肿瘤生物标志物:过去、现在与未来
J Clin Med. 2022 Sep 21;11(19):5542. doi: 10.3390/jcm11195542.
6
Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients' plasma.生长激素分泌型垂体神经内分泌肿瘤患者血浆中循环miRNA的全基因组分析。
Front Oncol. 2022 Sep 9;12:894317. doi: 10.3389/fonc.2022.894317. eCollection 2022.
7
Elevated miR-16-5p induces somatostatin receptor 2 expression in neuroendocrine tumor cells.miR-16-5p 水平升高可诱导神经内分泌肿瘤细胞生长抑素受体 2 的表达。
PLoS One. 2020 Oct 12;15(10):e0240107. doi: 10.1371/journal.pone.0240107. eCollection 2020.
8
TBR-760, a Dopamine-Somatostatin Compound, Arrests Growth of Aggressive Nonfunctioning Pituitary Adenomas in Mice.TBR-760,一种多巴胺-生长抑素复合物,可抑制侵袭性无功能性垂体腺瘤在小鼠中的生长。
Endocrinology. 2020 Aug 1;161(8). doi: 10.1210/endocr/bqaa101.
9
Special Issue: MicroRNA Regulation in Health and Disease.特刊:微小 RNA 在健康和疾病中的调控作用。
Genes (Basel). 2019 Jun 15;10(6):457. doi: 10.3390/genes10060457.
10
Treatment with somatostatin analogs induces differentially expressed let-7c-5p and mir-3137 in small intestine neuroendocrine tumors.生长抑素类似物治疗诱导小肠类癌中差异表达的 let-7c-5p 和 mir-3137。
BMC Cancer. 2019 Jun 13;19(1):575. doi: 10.1186/s12885-019-5794-y.
典型和非典型肺类癌的预后因素
Ochsner J. 2017 Winter;17(4):335-340.
4
Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease.肺神经内分泌肿瘤:分化良好疾病的诊断和治疗的当前挑战和进展。
J Thorac Oncol. 2017 Mar;12(3):425-436. doi: 10.1016/j.jtho.2016.11.2222. Epub 2016 Nov 24.
5
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.2015 年世界卫生组织肺肿瘤分类:自 2004 年分类以来遗传、临床和放射学进展的影响。
J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.
6
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.肺神经内分泌(类癌)肿瘤:欧洲神经内分泌肿瘤学会专家共识和典型与非典型肺类癌最佳实践建议。
Ann Oncol. 2015 Aug;26(8):1604-20. doi: 10.1093/annonc/mdv041. Epub 2015 Feb 2.
7
Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1.神经内分泌肿瘤及转移灶中miR-129-5p和let-7家族的下调导致其靶标Egr1、G3bp1、Hmga2和Bach1的上调。
Genes (Basel). 2014 Dec 24;6(1):1-21. doi: 10.3390/genes6010001.
8
The molecular mechanisms and therapeutic potential of microRNA-7 in cancer.微小RNA-7在癌症中的分子机制及治疗潜力
Expert Opin Ther Targets. 2015 Mar;19(3):415-26. doi: 10.1517/14728222.2014.988708. Epub 2014 Nov 29.
9
Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors.帕西瑞肽长效可重复制剂用于转移性神经内分泌肿瘤患者的II期临床试验。
Endocr Relat Cancer. 2015 Feb;22(1):1-9. doi: 10.1530/ERC-14-0360. Epub 2014 Nov 6.
10
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.兰瑞肽用于转移性胃肠胰神经内分泌肿瘤
N Engl J Med. 2014 Oct 16;371(16):1556-7. doi: 10.1056/NEJMc1409757.